Stock TARA PROTARA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Protara Therapeutics, Inc.

Equities

TARA

US74365U1079

Real-time Estimate Cboe BZX
Other stock markets
 03:30:28 2024-07-16 pm EDT 		5-day change 1st Jan Change
2.35 USD -1.26% Intraday chart for Protara Therapeutics, Inc. +14.08% +29.59%
May. 02 Protara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 Protara Therapeutics, Inc. announced that it has received $44.998327 million in funding from a group of investors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROTARA THERAPEUTICS, INC. Stock Protara Therapeutics, Inc.
 49M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 117B
ARGENX SE Stock argenx SE
 27.67B -
BIONTECH SE Stock BioNTech SE
 20.33B -
GENMAB A/S Stock Genmab A/S
 16.79B
  1. Stock Market
  2. Equities
  3. TARA Stock
  4. Charts Protara Therapeutics, Inc.
  5. Sector Chart